CS logo
small CS logo
Genesis Healthcare System Cancer Care Center

Zanesville, Ohio, United States
Cancer treatment center in Zanesville, Ohio
2951 Maple Ave, Zanesville, OH 43701

About Genesis Healthcare System Cancer Care Center


"Genesis Cancer Care Center"
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Genesis Healthcare System Cancer Care Center


During the past decade, Genesis Healthcare System Cancer Care Center conducted 135 clinical trials. In the 10-year time frame, 135 clinical trials started and 95 clinical trials were completed, i.e. on average, 70.4% percent of trials that started reached the finish line to date. In the past 5 years, 57 clinical trials started and 62 clinical trials were completed. i.e. 108.8% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Genesis Healthcare System Cancer Care Center" #1 sponsor was "National Cancer Institute (NCI)" with 115 trials, followed by "SWOG Cancer Research Network" with 36 trials sponsored, "Alliance for Clinical Trials in Oncology" with 23 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 11 trials sponsored and "NRG Oncology" with 11 trials sponsored. Other sponsors include 16 different institutions and companies that sponsored additional 12 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Genesis Healthcare System Cancer Care Center" #1 collaborator was "National Cancer Institute (NCI)" with 97 trials as a collaborator, "NRG Oncology" with 29 trials as a collaborator, "Canadian Cancer Trials Group" with 7 trials as a collaborator, "SWOG Cancer Research Network" with 6 trials as a collaborator and "Cancer and Leukemia Group B" with 5 trials as a collaborator. Other collaborators include 28 different institutions and companies that were collaborators in the rest 28 trials.

Clinical Trials Conditions at Genesis Healthcare System Cancer Care Center


According to Clinical.Site data, the most researched conditions in "Genesis Healthcare System Cancer Care Center" are "Recurrent Breast Carcinoma" (12 trials), "Recurrent Ovarian Carcinoma" (11 trials), "Stage IV Lung Cancer AJCC v8" (10 trials), "Recurrent Squamous Cell Lung Carcinoma" (9 trials) and "Stage IV Breast Cancer AJCC v6 and v7" (9 trials). Many other conditions were trialed in "Genesis Healthcare System Cancer Care Center" in a lesser frequency.

Clinical Trials Intervention Types at Genesis Healthcare System Cancer Care Center


Most popular intervention types in "Genesis Healthcare System Cancer Care Center" are "Drug" (168 trials), "Other" (146 trials), "Biological" (94 trials), "Procedure" (55 trials) and "Radiation" (27 trials). Other intervention types were less common.
The name of intervention was led by "Laboratory Biomarker Analysis" (78 trials), "Quality-of-Life Assessment" (68 trials), "Questionnaire Administration" (36 trials), "Carboplatin" (30 trials) and "Computed Tomography" (30 trials). Other intervention names were less common.

Clinical Trials Genders at Genesis Healthcare System Cancer Care Center


The vast majority of trials in "Genesis Healthcare System Cancer Care Center" are 160 trials for "All" genders, 51 trials for "Female" genders and 3 trials for "Male" genders.

Clinical Trials Status at Genesis Healthcare System Cancer Care Center


Currently, there are NaN active trials in "Genesis Healthcare System Cancer Care Center". undefined are not yet recruiting, 50 are recruiting, 107 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 43 completed trials in Genesis Healthcare System Cancer Care Center, 3 suspended trials, and 9 terminated clinical trials to date.
Out of the total trials that were conducted in Genesis Healthcare System Cancer Care Center, 8 "Phase 1" clinical trials were conducted, 100 "Phase 2" clinical trials and 112 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 5 trials that are defined as “Not Applicable".